The bio sector is littered with Phase 1, 2 & 3 trials where companies have spent millions of $ and failed to take the product to the next stage or commercialised.
Just because we have Professor Fraser and his team working on this guarantees nothing and they might have a far greater understanding of how they expect the vac to work, but they don't know the results until they are released to them.
I think AHZ has amazing products but let's keep it real, getting the vac to market is still a long shot. For me that's the chance of blue sky but I'm here for adapt.
hsv2 final results, page-7
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.05 |
Change
-0.100(0.66%) |
Mkt cap ! $289.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $54.06K | 3.559K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15 | $15.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.16 | 356 | 3 |
View Market Depth
| Last trade - 14.04pm 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |